Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dow Stough, MD
Burke Pharmaceutical Research
Principal Investigator - Fran Cook-Bolden, MD
Skin Specialty Dermatology
Principal Investigator - Ian Landells, MD
Nexus Clinical Research
Principal Investigator - Kirk Barber, MD
Kirk Barber Research Inc.
Principal Investigator - Leslie Baumann, MD
Baumann Cosmetic and Research Institute
Principal Investigator - Mark Ling, MD
MedaPhase, Inc.
Principal Investigator - Michael Graeber, MD
Galderma R&D
Study Chair - Michael Heffernan, MD
Central Dermatology
Principal Investigator - Patricia Westmoreland, MD
Palmetto Clinical Trials Services, LLC
Principal Investigator - Phoebe Rich, MD
Oregon Dermatology and Research Center
Principal Investigator - Robert Haber, MD
Haber Dermatology & Cosmetic Surgery
Principal Investigator - Steven Grekin, DO
Grekin Skin Institute
Principal Investigator - Terry Jones, MD
J&S Studies Inc.
Principal Investigator - Wayne Gulliver, MD
Newlab Clinical Research Inc.
Principal Investigator - William Werschler, MD
Premier Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kirk Barber Research Inc.
Calgary, Alberta, Canada
- Newlab Clinical Research Inc.
St. John's, Newfoundland and Labrador, Canada
- Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
- Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
- Baumann Cosmetic and Research Institute
Miami Beach, Florida, United States
- Medaphase, Inc.
Newnan, Georgia, United States
- Dermatology Specialists Research
Louisville, Kentucky, United States
- Grekin Skin Institute
Warren, Michigan, United States
- Central Dermatology Pc
St Louis, Missouri, United States
- Skin Specialty Dermatology
New York, New York, United States
- Haber Dermatology & Cosmetic Surgery
South Euclid, Ohio, United States
- Oregon Dermatology and Research Center
Portland, Oregon, United States
- Palmetto Clinical Trial Services, Llc
Greenville, South Carolina, United States
- J&s Studies Inc.
College Station, Texas, United States
- Premier Clinical Research
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Nov 2011
- Completion
- 31 Jan 2012
- Last update posted
- 18 Feb 2021
- Registered enrollment
- 293
- Registry id
- NCT01355471
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.